logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hongmei Jing

Peking University Third Hospital
H指数:26
被引数:2,792

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy

格卡罗替尼、非达替尼、帕克里替尼和莫美洛替尼在二线骨髓纤维化治疗中的匹配调整间接比较

Hematological Oncology
IF3.9
2026-09-300
PRE
Yi Zhang; Hu Zhou; Qike Zhang; Qingchi Liu; Sujun Gao; Zhijian Xiao; Minghui Duan; Liangming Ma; Wei Wang; Huibing Dang; Guangsheng He; Hongmei Jing; Junmin Li; Haiping Yang; Huanling Zhu; Chunkang Chang; Yuqing Chen; Xin Du; Mei Hong; Xin Li; Jishi Wang; Na Xu; Shanshan Suo; Jie Jin
Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial

低剂量巴瑞替尼联合达那唑治疗原发性免疫性血小板减少症：一项随机对照2期临床试验

Nature Communications
IF15.7
2026-07-250
OAAI
Peng Zhao; Zhuo-Yu An; Hai-Xia Fu; Yang Wang; Guo-Shuang Feng; Hui-Xin Liu; Dai-Hong Liu; Yi Liu; He-Bing Zhou; Hui Liu; Zhao Wang; Yu-Jun Dong; Hong-Mei Jing; Zhen-Ling Li; Li-Hong Li; Li-Ping Dou; Qiu-Sha Huang; Jin Wu; Li-Ping Yang; Yue Jin; Zhi-Xue Li; Chen-Cong Wang; Qi Chen; Xiao-Lu Zhu; Yun He; Yuan-Yuan Zhang; Qian Jiang; Hao Jiang; Jin Lu; Ying-Jun Chang; Xiang-Yu Zhao; Xiao-Jun Huang; Xiao-Hui Zhang
Pre-Transplant MRD Negativity and Age Under 40 Predict Superior Long-Term Survival in Relapsed/Refractory B-ALL After CAR-T Therapy Bridging to Haploidentical HSCT: A Multicenter Retrospective Study With 6-Year Follow-Up

移植前微小残留病阴性及年龄小于40岁预测CAR-T治疗后复发/难治性B-ALL行半相合造血干细胞移植桥接治疗患者的长期生存优势：一项随访6年的多中心回顾性研究

American Journal of Hematology
IF9.9
2026-05-130
PRE
Houli Zhao; Zhouning Lin; Haiqiong Zheng; Guoqing Wei; Yi Luo; Jimin Shi; Qu Cui; Mingfeng Zhao; Aibin Liang; Qing Zhang; Jianmin Yang; Xin Li; Jing Chen; Xianmin Song; Hongmei Jing; Yuhua Li; Siguo Hao; Wenjun Wu; Elaine Tan Su Yin; Yamin Tan; Jian Yu; Yanmin Zhao; Xiaoyu Lai; Yunxiong Wei; Ping Li; Jing Huang; Tao Wang; Didier Blaise; Lei Xiao; Alex H. Chang; Arnon Nagler; Garret Leung; Mohamad Mohty; He Huang; Yongxian Hu
A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma

一个结合深度学习基线PET/CT生物标志物和多组学分析谱的弥漫性大B细胞淋巴瘤预后指数

Cell Reports Medicine
IF10.6
2025-11-180
OAAI
Yue Wang; Xue Wang; Xin-Yun Huang; Hong-Mei Jing; Song-Fu Jiang; He Li; Rong-Ji Mu; Qing Shi; Di Fu; Zhuo-Han Li; Hong-Mei Yi; Bin-Shen Ouyang; Biao Li; Fu-Hua Yan; Ting Niu; Shu Cheng; Li Wang; Ning Wen; Peng-Peng Xu; Wei-Li Zhao
Phase 2 Study of Relmacabtagene Autoleucel (CD19 CAR-T) for Relapsed/Refractory Mantle Cell Lymphoma in Chinese Adults

II期研究：评估Relmacabtagene autoleucel（CD19 CAR-T）治疗中国成人复发/难治性套细胞淋巴瘤的疗效

Blood Advances
IF7.1
2025-11-100
OAAI
Yan Xie; Ke-Shu Zhou; Lan-Fang Li; Ai-Bin Liang; Heng Mei; De-hui Zou; Wen-Yu Li; Jie Jin; Zheng-Ming Jin; Hong-Mei Jing; Hai-Yan Yang; Tong Chen; Hui-Qiang Huang; Peng-Cheng He; Jun-Ning Cao; Zhen Xia; Yong-En Gu; Yi-Bei Zang; Zi-Song Zhou; Zhao-Zhao Tian
Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma

II期研究：zevorcabtagene autoleucel，一种靶向BCMA的全人源CAR T细胞疗法，在复发/难治性多发性骨髓瘤患者中的应用

Experimental Hematology & Oncology
IF13.5
2025-10-020
OAAI
Wenming Chen; Chengcheng Fu; Baijun Fang; Aibin Liang; Zhongjun Xia; Yanjuan He; Jin Lu; Hui Liu; Ming Hou; Zhen Cai; Wei Yang; Siguo Hao; Songfu Jiang; Hongmei Jing; Jing Liu; Xin Du; Rong Fu; Heng Mei; Zunmin Zhu; Yanli Yang; Hong Liu; Xingxing Meng; Nishanthan Rajakumaraswamy; Daijing Yuan; Huamao Wang; Zonghai Li
Correlation Between Fecal Microbiota and Corticosteroid Responsiveness in Primary Immune Thrombocytopenia: an Exploratory Study (Adv. Sci. 22/2025)

粪便微生物群与原发性免疫性血小板减少症糖皮质激素反应性之间的关系：一项探索性研究（Adv. Sci. 22/2025）

Advanced Science
IF14.1
2025-06-120
OA
Feng-Qi Liu; Zhuo-Yu An; Li-Juan Cui; Meng-Yu Xiao; Ye-Jun Wu; Wei Li; Bang-Shuo Zhang; Li Yu; Jia Feng; Zhuo-Gang Liu; Ru Feng; Zhong-Xing Jiang; Rui-Bin Huang; Hong-Mei Jing; Jin-Hai Ren; Xiao-Yu Zhu; Yun-Feng Cheng; Yu-Hua Li; He-Bing Zhou; Da Gao; Yi Liu; Fan Yu; Xin Wang; Jian-Lin Qiao; Dai-Hong Hu; Lu-Lu Wang; Meng-Tong Zang; Qi Chen; Qing-Yuan Qu; Jian-Ying Zhou; Meng-Lin Li; Yu-Xiu Chen; Qiu-Sha Huang; Hai-Xia Fu; Yue-Ying Li; Qian-Fei Wang; Xiao-Jun Huang; Xiao-hui Zhang; the Cooperative ITP Working Group; Feng-Qi Liu; Zhuo-Yu An; Li-Juan Cui; Meng-Yu Xiao; Ye-Jun Wu; Wei Li; Bang-Shuo Zhang; Li Yu; Jia Feng; Zhuo-Gang Liu; Ru Feng; Zhong-Xing Jiang; Rui-Bin Huang

研究方向

暂未获取到该数据
P
Ping Yang
H 指数:31论文数:342被引数:3,771
W
Weilong Zhang
H 指数:14论文数:100被引数:1,101
K
Kai Hu
H 指数:16论文数:131被引数:738
J
Jing Wang
H 指数:43论文数:532被引数:7,628
X
Xiuru Zhang
H 指数:17论文数:73被引数:769
X
Xiaoni Liu
H 指数:18论文数:107被引数:1,433
X
Xue He
H 指数:12论文数:48被引数:724
W
Weiyou Liu
H 指数:13论文数:27被引数:351
X
Xiaoliang Yuan
H 指数:20论文数:80被引数:1,598
H
Huilai Zhang
H 指数:37论文数:375被引数:5,176